DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for BioCryst Pharmaceuticals, Inc. (BCRX)
« Back to company indexBCRX Chatter Timeline
Stock Ticker for BCRX
Most Active Tweeters for BCRX
No tweets foundRecent Tweets for BCRX
 |
@EnterpriseLeade Alps Advisors Inc. Sells 22,977 Shares of BioCryst Pharmaceuticals, Inc. $BCRX https://t.co/vc531IHyqo August 21st 2018, 5:08pm |
 |
@MareaInformativ Jennison Associates LLC Has $19.89 Million Stake in BioCryst Pharmaceuticals, Inc. $BCRX https://t.co/rFUZxk0o0s August 21st 2018, 4:08pm |
 |
@TheMarketsDaily BioCryst Pharmaceuticals, Inc. $BCRX Receives $10.08 Consensus Target Price from Analysts https://t.co/xZjkfkv0ut August 21st 2018, 4:08pm |
 |
@CPulses $BCRX Continues to Shape-Up and remains technically constructive consolidating the recent thrust. #BCRX #Biotech https://t.co/5X66GMLtKW August 21st 2018, 1:08pm |
 |
@ThisLincolnian Zacks: Brokerages Expect BioCryst Pharmaceuticals, Inc. $BCRX Will Announce Quarterly Sales of $6.89 Million https://t.co/Z28gCehp2J August 21st 2018, 8:08am |
 |
@ChickenhawkBob Bought $BCRX including E.T.P.C. tool thoughts https://t.co/EErhL7E3Ef August 20th 2018, 12:08pm |
 |
@bioswingpattern $bcrx break and back testing 200 week moving avg. https://t.co/O4HLli1dlg August 19th 2018, 2:08pm |
|
@TheMarketsDaily Head to Head Contrast: BioCryst Pharmaceuticals $BCRX versus Vaxart $VXRT https://t.co/3HrwxN6sm7 August 19th 2018, 11:08am |
|
@EnterpriseLeade BioCryst Pharmaceuticals $BCRX Rating Increased to Buy at BidaskClub https://t.co/HUmGlwRXV0 August 19th 2018, 8:08am |
 |
@AmericanBanking BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Earnings of -$0.20 Per Share https://t.co/xaYnkw7WMX #stocks August 19th 2018, 4:08am |
 |
@ConsumerFeed Analysts Anticipate BioCryst Pharmaceuticals, Inc. $BCRX Will Post Earnings of -$0.20 Per Share https://t.co/mho8M7NSNs August 19th 2018, 4:08am |
|
@EnterpriseLeade Comparing BioCryst Pharmaceuticals $BCRX and Brainstorm Cell Therapeutics $BCLI https://t.co/LNvZEralkf August 19th 2018, 1:08am |
|
@AmericanBanking BioCryst Pharmaceuticals, Inc. $BCRX Receives Average Recommendation of “Buy” from Analysts https://t.co/lVWiapGxbP #stocks August 18th 2018, 2:08pm |
 |
@TranscriptDaily BioCryst Pharmaceuticals, Inc. $BCRX Receives Average Recommendation of “Buy” from Analysts https://t.co/9gWTu0I0DW August 18th 2018, 2:08pm |
 |
@filing_scanner $BCRX New Insider Filing On: Sheridan William P Transaction Code: M https://t.co/Jute3Y1A09 August 18th 2018, 2:08am |
 |
@WatchlistN BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reaffirmed at HC Wainwright https://t.co/HMpcGsN4Sv August 17th 2018, 8:08am |
|
@MareaInformativ BioCryst Pharmaceuticals $BCRX Upgraded by ValuEngine to “Buy” https://t.co/dHKA2LG9lT August 16th 2018, 12:08pm |
 |
@dakotafinancial BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reiterated at HC Wainwright https://t.co/jaLd8mYoib August 16th 2018, 5:08am |
|
@EnterpriseLeade $6.51 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/FjyoQCItlE August 15th 2018, 11:08pm |
 |
@OlympiaReport BioCryst Pharmaceuticals $BCRX Reaches New 1-Year High at $7.49 https://t.co/rrqurkW12K August 15th 2018, 5:08pm |
 |
@dispatchtribune BioCryst Pharmaceuticals $BCRX Sets New 52-Week High at $7.49 https://t.co/aN7SKGigat August 15th 2018, 5:08pm |
 |
@registrarjourn BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reaffirmed at HC Wainwright https://t.co/s85PJD3QoD August 15th 2018, 11:08am |
|
@EnterpriseLeade BioCryst Pharmaceuticals’ $BCRX “Buy” Rating Reaffirmed at HC Wainwright https://t.co/WaTyqQJR8m August 15th 2018, 11:08am |
 |
@ChartMill Although $BCRX has an excellent technical rating, it does not offer a high quality setup at the moment.… https://t.co/IZPplBv8Re August 15th 2018, 9:08am |
|
@TranscriptDaily Insider Selling: BioCryst Pharmaceuticals, Inc. $BCRX CMO Sells 62,500 Shares of Stock https://t.co/GP43fnOgyX August 15th 2018, 5:08am |
|
@dispatchtribune BioCryst Pharmaceuticals, Inc. Expected to Post Q3 2018 Earnings of -$0.23 Per Share $BCRX https://t.co/mPIEtSeI7z August 15th 2018, 5:08am |
|
@OlympiaReport BioCryst Pharmaceuticals, Inc. Expected to Post Q3 2018 Earnings of -$0.23 Per Share $BCRX https://t.co/TlmwlMIS8e August 15th 2018, 5:08am |
|
@AmericanBanking Research Analysts’ Recent Ratings Updates for BioCryst Pharmaceuticals $BCRX https://t.co/G3nBFZ8bIG #stocks August 15th 2018, 4:08am |
|
@ConsumerFeed Research Analysts’ Recent Ratings Updates for BioCryst Pharmaceuticals $BCRX https://t.co/HabcKMVBOM August 15th 2018, 4:08am |
|
@filing_scanner $BCRX New Insider Filing On: Sheridan William P Transaction Code: M https://t.co/Jute3XJYBz August 14th 2018, 2:08pm |
 |
@WeekHerald BioCryst Pharmaceuticals $BCRX Receives “Buy” Rating from HC Wainwright https://t.co/cH6Pl9rwY4 August 14th 2018, 10:08am |
|
@ThisLincolnian BioCryst Pharmaceuticals $BCRX Receives “Buy” Rating from HC Wainwright https://t.co/kWKckGKoZS August 14th 2018, 10:08am |
 |
@bbnsnews BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares of Stock https://t.co/JIW1ECdgQg August 14th 2018, 6:08am |
|
@WatchlistN Q3 2018 Earnings Forecast for BioCryst Pharmaceuticals, Inc. $BCRX Issued By Jefferies Financial Group https://t.co/R2kGq9RNNb August 14th 2018, 4:08am |
|
@TranscriptDaily BioCryst Pharmaceuticals $BCRX Raised to Buy at BidaskClub https://t.co/eOMa9MvK5f August 14th 2018, 2:08am |
|
@MareaInformativ BioCryst Pharmaceuticals $BCRX Sets New 52-Week High at $7.49 https://t.co/H42N4SXJRV August 13th 2018, 6:08pm |
|
@TheMarketsDaily BioCryst Pharmaceuticals $BCRX Sets New 52-Week High at $7.49 https://t.co/dBkcrBx53C August 13th 2018, 6:08pm |
|
@MareaInformativ BioCryst Pharmaceuticals $BCRX Receives Daily Coverage Optimism Score of -0.04 https://t.co/hgG0fxKGDH August 13th 2018, 6:08pm |
|
@AmericanBanking BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares https://t.co/vXwJ9ny3B4 #stocks August 13th 2018, 1:08pm |
|
@OlympiaReport William P. Sheridan Sells 62,500 Shares of BioCryst Pharmaceuticals, Inc. $BCRX Stock https://t.co/JAX5uJz117 August 13th 2018, 1:08pm |
|
@dispatchtribune BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares https://t.co/ZVsPgmK6w1 August 13th 2018, 1:08pm |
|
@MareaInformativ BioCryst Pharmaceuticals, Inc. $BCRX CMO William P. Sheridan Sells 62,500 Shares https://t.co/jOIb44K0LS August 13th 2018, 1:08pm |
|
@AmericanBanking BioCryst Pharmaceuticals $BCRX Receives Buy Rating from HC Wainwright https://t.co/5RjXkwkaXt #stocks August 13th 2018, 1:08pm |
 |
@InsiderAlertsIA $BCRX: New Insider Filing on Senior VP - CMO WILLIAM P SHERIDAN: https://t.co/Sk6KHS4kke August 13th 2018, 11:08am |
 |
@Allstocknews $BCRX New Form 4 for BioCryst Pharmaceutical, Inc. From our Stock News Alerts App August 13th 2018, 10:08am |
 |
@StockTexts $BCRX BioCryst Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/x7zdKOrBZU August 13th 2018, 10:08am |
|
@MareaInformativ BioCryst Pharmaceuticals, Inc. $BCRX Given Consensus Rating of “Hold” by Analysts https://t.co/AatWhoerC1 August 13th 2018, 8:08am |
 |
@stocknewsdotcom $BCRX H.C. Wainwright & Co. reiterates Buy rating, $13 PT https://t.co/fF2Gh9junu August 13th 2018, 8:08am |
|
@OlympiaReport BioCryst Pharmaceuticals $BCRX Upgraded by BidaskClub to “Buy” https://t.co/pX68dmsZ67 August 13th 2018, 7:08am |
|
@TheMarketsDaily BioCryst Pharmaceuticals $BCRX Given Buy Rating at HC Wainwright https://t.co/qpNEYH4fsk August 13th 2018, 7:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.